Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Platinum Compounds × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 20 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Retinoblastoma 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Sjogren's Syndrome 1 Scleroderma, Systemic 1 Retinal Neoplasms 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Recurrence 1 Psoriasis 1 Ovarian Neoplasms 1 Ovarian Cancer Recurrent 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Multiple Sclerosis 1 Melanoma 1 Lymphatic Metastasis 1 Lupus Erythematosus, Systemic 1 Inflammatory Bowel Diseases 1 Hematologic Neoplasms 1 Dermatomyositis 1 Crohn Disease 1 Colorectal Neoplasms 1 Colitis, Ulcerative 1 Carcinoma, Squamous Cell 1

Interventions

Cyclophosphamide 50 fludarabine 37 Dexamethasone 35 venetoclax 31 pembrolizumab 24 Rituximab 20 Lenalidomide 18 Gemcitabine 18 pomalidomide 16 fludarabine phosphate 15 Etoposide 14 Cytarabine 14 carfilzomib 12 daratumumab 11 Temozolomide 11 Calcium Dobesilate 11 Nivolumab 10 Cisplatin 10 Azacitidine 10 glofitamab 9 Vincristine 9 Injections 9 obinutuzumab 8 Carboplatin 8 selinexor 7 Immunotherapy, Adoptive 7 Doxorubicin 7 Decitabine 7 Bortezomib 7 Bevacizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340164 2026-04-20

TROY

Yonsei University

Phase 2 Recruiting

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡